Brainstorm Cell Theraputc (BCLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,825 | -1,785 | -4,982 | -4,358 | -2,752 |
| Depreciation Amortization | 34 | 16 | 712 | 691 | 503 |
| Accounts receivable | -511 | 76 | 379 | 641 | -499 |
| Other Working Capital | -664 | 1 | -1,709 | -1,116 | -2,169 |
| Other Operating Activity | 694 | 50 | -258 | -520 | 530 |
| Operating Cash Flow | $-3,272 | $-1,642 | $-5,858 | $-4,662 | $-4,387 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 8,510 | 1,700 | 6,084 | 5,289 | 4,990 |
| PPE Investments | -32 | N/A | -103 | -96 | -85 |
| Purchase Of Investment | 1 | -1 | -4 | -4 | -2 |
| Investing Cash Flow | $8,479 | $1,699 | $5,977 | $5,189 | $4,903 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 30 | N/A | N/A | N/A | N/A |
| Financing Cash Flow | $30 | $N/A | $N/A | $N/A | $N/A |
| Beginning Cash Position | 547 | 547 | 428 | 428 | 428 |
| End Cash Position | 5,784 | 604 | 547 | 955 | 944 |
| Net Cash Flow | $5,237 | $57 | $119 | $527 | $516 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,272 | -1,642 | -5,858 | -4,662 | -4,387 |
| Capital Expenditure | -32 | N/A | -103 | -96 | -85 |
| Free Cash Flow | -3,304 | -1,642 | -5,961 | -4,758 | -4,472 |